Substandard medicines refer to pharmaceutical products that fail to meet quality standards. They may contain incorrect ingredients or inadequate dosages. These medicines can pose serious health risks to patients. The issue is prevalent in many countries, including India. Regulatory bodies strive to combat this problem. Awareness is crucial for public safety. Consumers must be vigilant when purchasing medicines.
Rajasthan issued an immediate ban on the sale, distribution, and use of seven medicines on 22 April 2026 after laboratory testing found them to be substandard. The Commissionerate...
